CC12, a P450/epoxygenase inhibitor, acts in the rat rostral, ventromedial medulla to attenuate morphine antinociception.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Brain Research

• Publication date

  2013-03-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.brainres.2012.12.030PMID 23298831PMCID PMC3570688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signaling Cascades for δ-Opioid Receptor-Mediated Inhibition of GABA Synaptic Transmission and Behavioral Antinociception

  2012influential reference
• Opioid analgesics

  2011cited by this paper
• Opioids Activate Brain Analgesic Circuits Through Cytochrome P450/Epoxygenase Signaling

  2010cited by this paper
• Physiological basis for inhibition of morphine and improgan antinociception by CC12, a P450 epoxygenase inhibitor.

  2010cited by this paper
• High-Affinity Binding of [3H]Cimetidine to a Heme-Containing Protein in Rat Brain

  2008cited by this paper
• Periaqueductal gray neurons project to spinally projecting GABAergic neurons in the rostral ventromedial medulla

  2008cited by this paper
• CC12, a high-affinity ligand for [3H]cimetidine binding, is an improgan antagonist.

  2007cited by this paper
• Activation of brain stem nuclei by improgan, a non-opioid analgesic.

  2004cited by this paper
• Spinal G-Protein-Gated K+ Channels Formed by GIRK1 and GIRK2 Subunits Modulate Thermal Nociception and Contribute to Morphine Analgesia

  2004cited by this paper
• Disruption of the type 1 inositol 1,4,5-trisphosphate receptor gene suppresses the morphine-induced antinociception in the mouse.

  2003cited by this paper
• Augmented responses to morphine and cocaine in mice with a 12-lipoxygenase gene disruption

  2003cited by this paper
• Direct evidence for the activation of phospholipase Cγ1 by in vivo treatment with morphine in the mouse periaqueductal gray matter

  2003cited by this paper
• Direct evidence for the activation of phospholipase C gamma 1 by in vivo treatment with morphine in the mouse periaqueductal gray matter.

  2003cited by this paper
• Comparison of morphine and kainic acid microinjections into identical PAG sites on the activity of RVM neurons.

  2002cited by this paper
• The role of descending fibers from the rostral ventromedial medulla in opioid analgesia in rats.

  2002cited by this paper
• Descending control of pain.

  2002cited by this paper
• Activation of brainstem N‐methyl‐D‐aspartate receptors is required for the analgesic actions of morphine given systemically

  2001cited by this paper
• Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla.

  2001cited by this paper
• CaMKIIalpha-Cre transgene expression and recombination patterns in the mouse brain.

  2000cited by this paper
• CaMKIIα‐cre transgene expression and recombination patterns in the mouse brain

  2000cited by this paper
• Molecular mechanisms and regulation of opioid receptor signaling.

  2000cited by this paper
• Cellular Actions Of Opioids And Other Analgesics: Implications For Synergism In Pain Relief

  2000cited by this paper
• Opioids, NSAIDs and 5-lipoxygenase inhibitors act synergistically in brain via arachidonic acid metabolism

  1999cited by this paper
• Mu and kappa opioid receptors in periaqueductal gray and rostral ventromedial medulla

  1998cited by this paper
• The contribution of the rostral ventromedial medulla to the antinociceptive effects of systemic morphine in restrained and unrestrained rats.

  1998cited by this paper
• Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ

  1997cited by this paper
• Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla.

  1997cited by this paper
• How opioids inhibit GABA-mediated neurotransmission

  1997cited by this paper
• Opioid inhibition of rat periaqueductal grey neurones with identified projections to rostral ventromedial medulla in vitro.

  1996cited by this paper
• Endogenous opioid-mediated inhibition of putative pain-modulating neurons in rat rostral ventromedial medulla.

  1996cited by this paper
• Descending control of pain.

  1995cited by this paper
• Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS.

  1995cited by this paper
• Nuclei within the rostral ventromedial medulla mediating morphine antinociception from the periaqueductal gray.

  1994cited by this paper
• Interference with GABA transmission in the rostral ventromedial medulla: disinhibition of off-cells as a central mechanism in nociceptive modulation.

  1994cited by this paper
• Medullary μ and δ opioid receptors modulate mesencephalic morphine analgesia in rats

  1993cited by this paper
• Medullary mu and delta opioid receptors modulate mesencephalic morphine analgesia in rats.

  1993cited by this paper
• Cloning and pharmacological characterization of a rat mu opioid receptor.

  1993cited by this paper
• Synergistic brainstem interactions for morphine analgesia.

  1993cited by this paper
• GABA‐mediated inhibition in rostral ventromedial medulla: role in nociceptive modulation in the lightly anesthetized rat

  1991cited by this paper
• Roles of periaqueductal gray and nucleus raphe magnus on analgesia induced by lappaconitine, N-deacetyllappaconitine and morphine.

  1990cited by this paper
• Cholecystokinin-octapeptide antagonizes morphine analgesia in periaqueductal gray of the rat.

  1989cited by this paper
• Chapter 28 Sites of action of opiates in production of analgesia

  1988cited by this paper
• Intrathecal administration: methodological considerations.

  1988cited by this paper
• Sites of action of opiates in production of analgesia.

  1988cited by this paper
• GABAergic modulation of the analgesic effects of morphine microinjected in the ventral periaqueductal gray matter of the rat.

  1987cited by this paper
• I. Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat

  1986cited by this paper
• Goodman and Gilman's The Pharmacological Basis of Therapeutics

  1986cited by this paper
• Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission.

  1986cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983influential reference
• Periaqueductal gray matter involvement in the muscimol-induced decrease of morphine antinociception

  1982cited by this paper
• Sites of antinociceptive action of systemically injected morphine: involvement of supraspinal loci as revealed by intracerebroventricular injection of naloxone.

  1980cited by this paper
• Simple cannula for repeated intracerebral drug administration in rats.

  1979cited by this paper
• Explosive motor behavior, rigidity and periaqueductal gray lesions.

  1978cited by this paper
• Explosive motor behavior, rigidity and periaqueductal gray lesions

  1978influential reference
• Periaqueductal grey lesions reduce morphine analgesia in the rat.

  1977cited by this paper
• Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques

  1977cited by this paper
• Systematic examination in the rat of brain sites sensitive to the direct application of morphine: Observation of differential effects within the periaqueductal gray

  1976influential reference
• Analgesia and hyperractivity following morphine microinjection into mouse brain.

  1976cited by this paper
• Chronic catheterization of the spinal subarachnoid space.

  1976cited by this paper
• The Pharmacological Basis of Therapeutics

  1976cited by this paper
• Analgesia and hyperreactivity produced by intracranial microinjections of morphine into the periaqueductal gray matter of the rat.

  1974cited by this paper
• Morphine Action at Central Nervous System Sites in Rat: Analgesia or Hyperalgesia Depending on Site and Dose

  1973cited by this paper
• Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines.

  1953cited by this paper
• A METHOD FOR DETERMINING LOSS OF PAIN SENSATION

  1941cited by this paper

• Lipid mediators generated by the cytochrome P450-Epoxide hydrolase pathway.

  2023cites this paper
• G protein‐coupled estrogen receptor in the rostral ventromedial medulla contributes to the chronification of postoperative pain

  2021cites this paper
• Douleur et thermorégulation Les effets ambivalents de la morphine

  2018cites this paper
• Expression of aromatase in the rostral ventromedial medulla and its role in the regulation of visceral pain

  2017cites this paper
• Epoxy fatty acids mediate analgesia in murine diabetic neuropathy

  2017cites this paper
• Entanglement between thermoregulation and nociception in the rat: the case of morphine.

  2016cites this paper
• Neuronal cytochrome P450 activity and opioid analgesia: relevant sites and mechanisms.

  2015cites this paper
• Opioid Analgesia in P450 Gene Cluster Knockout Mice: A Search for Analgesia-Relevant Isoforms

  2015cites this paper
• Opioid Analgesia in P 450 Gene Cluster Knockout Mice : A Search for Analgesia-Relevant Isoforms s

  2015cites this paper
• Microsoft Word-3329786-file00.docx

  2015cites this paper
• Deficits in neuronal cytochrome P450 activity attenuate opioid analgesia but not opioid side effects.

  2014cites this paper
• Significance of neuronal cytochrome P450 activity in opioid-mediated stress-induced analgesia.

  2014cites this paper
• Endogenous opiates and behavior: 2013.

  2014cites this paper
• Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance

  2013cites this paper